The therapeutic effect of a combination of cofpropamine, a caffeine derivative, and cyclophosphamide on the development of adjuvant arthritis of rats and collagen arthritis of mice

被引:4
作者
Kroger, H
Klosa, J
Gratz, R
Dietrich, A
Ehrlich, W
Wild, A
机构
[1] ROBERT KOC INST, D-13353 BERLIN, GERMANY
[2] E MERCK AG, D-6100 DARMSTADT, GERMANY
来源
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM | 1996年 / 27卷 / 07期
关键词
cyclophosphamide; cofpropamine; adjuvant arthritis; collagen arthritis;
D O I
10.1016/S0306-3623(96)00069-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. Cofpropamine(Cofa), a caffeine derivative that inhibits polyadenoribosylation, enhances the therapeutic effect of cyclophosphamide (CPA) in two animal models of arthritis. 2. The development of adjuvant arthritis of rats is reduced by treatment with 2 x 50 mg/kg IP CPA and 2 x 50 mg/kg IP Cofa. 3. The development of collagen arthritis in mice is prevented by treatment with 12.5 mg/kg IP CPA and 150 mg/kg IP Cofa three times per week. Copyright (C) 1996 Elsevier Science Inc.
引用
收藏
页码:1215 / 1218
页数:4
相关论文
共 24 条
[1]   CHEMOTHERAPEUTIC ACTION OF A CYCLIC NITROGEN MUSTARD PHOSPHAMIDE ESTER (B 518-ASTA) IN EXPERIMENTAL TUMOURS OF THE RAT [J].
ARNOLD, H ;
BOURSEAUX, F ;
BROCK, N .
NATURE, 1958, 181 (4613) :931-931
[2]   CYTOGENETIC TOXICITY OF CYCLOPHOSPHAMIDE AND ITS METABOLITES INVITRO [J].
AU, W ;
SOKOVA, OI ;
KOPNIN, B ;
ARRIGHI, FE .
CYTOGENETICS AND CELL GENETICS, 1980, 26 (2-4) :108-116
[3]   PROLONGATION OF HOMOGRAFT SURVIVAL IN MICE WITH SINGLE DOSES OF CYCLOPHOSPHAMIDE [J].
BERENBAUM, MC ;
BROWN, IN .
NATURE, 1963, 200 (490) :84-&
[4]  
BOREK C, 1984, P NATL ACAD SCI-BIOL, V81, P243, DOI 10.1073/pnas.81.1.243
[5]  
BROCK N, 1971, CANCER, V27, P1512, DOI 10.1002/1097-0142(197106)27:6<1512::AID-CNCR2820270636>3.0.CO
[6]  
2-Q
[7]   PREVENTION OR DELAY OF TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS IN CHILDREN USING NICOTINAMIDE [J].
ELLIOTT, RB ;
CHASE, HP .
DIABETOLOGIA, 1991, 34 (05) :362-365
[8]   DNA STRAND BREAKS AND ADP-RIBOSYL TRANSFERASE ACTIVATION DURING CELL-DIFFERENTIATION [J].
FARZANEH, F ;
ZALIN, R ;
BRILL, D ;
SHALL, S .
NATURE, 1982, 300 (5890) :362-366
[9]   THE ROLE OF INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE AS RESISTANCE-MODIFYING AGENTS IN CANCER-THERAPY [J].
GRIFFIN, RJ ;
CURTIN, NJ ;
NEWELL, DR ;
GOLDING, BT ;
DURKACZ, BW ;
CALVERT, AH .
BIOCHIMIE, 1995, 77 (06) :408-422
[10]   INACTIVATION OF THE POLY(ADP-RIBOSE) POLYMERASE GENE AFFECTS OXYGEN RADICAL AND NITRIC-OXIDE TOXICITY IN ISLET CELLS [J].
HELLER, B ;
WANG, ZQ ;
WAGNER, EF ;
RADONS, J ;
BURKLE, A ;
FEHSEL, K ;
BURKART, V ;
KOLB, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (19) :11176-11180